Nurse Practitioner · Springfield, OR
NPI
1366858334
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1 Hayden Bridge Way
Springfield, OR, 97477
Phone (541) 868-9430
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
378 services
Medicare patients, 2024
95
Average age 64
Drug cost, 2024
$1.3M
2,927 prescriptions
Company payments, 2025
$21K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alicia L Duyvejonck was code 99214 (office e&m - established), 120 times for 64 patients. In total Alicia L Duyvejonck billed 378 services in 11 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 120 | 64 | $55.19 | $6,623 |
| 99213 Office E&M - Established | Facility | 86 | 58 | $34.47 | $2,965 |
| 64615 Musculoskeletal | Facility | 84 | 30 | $65.16 | $5,473 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 51 | 43 | $10.36 | $528 |
By year: 2022 $40K for 5,484 services; 2023 $15K for 284 services; 2024 $17K for 378 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alicia L Duyvejonck prescribed most often to Medicare patients was Ubrelvy (Ubrogepant), with 261 prescriptions and refills. In total Alicia L Duyvejonck wrote 2,927 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ubrelvy Ubrogepant | 261 | 262 | 64 | $410K |
| Aimovig Autoinjector Erenumab-Aooe | 156 | 168 | 21 | $124K |
| Pregabalin Generic | 143 | 229 | 29 | $6,189 |
| Qulipta Atogepant | 128 | 130 | 18 | $131K |
| Amitriptyline Hcl Generic | 122 | 214 | 26 | $2,830 |
| Cyclobenzaprine Hcl Generic | 121 | 175 | 28 | $1,295 |
| Reyvow Lasmiditan Succinate | 117 | 121 | 29 | $102K |
| Nurtec Odt Rimegepant Sulfate | 116 | 116 | 30 | $144K |
| Emgality Pen Galcanezumab-Gnlm | 107 | 115 | 18 | $81K |
| Ondansetron Odt Ondansetron | 95 | 101 | 29 | $1,364 |
| Gabapentin Generic | 94 | 213 | 27 | $2,638 |
| Rizatriptan Rizatriptan Benzoate | 90 | 90 | 19 | $1,681 |
| Metoclopramide Hcl Generic | 77 | 85 | 24 | $164 |
| Duloxetine Hcl Generic | 74 | 142 | 15 | $1,049 |
| Topiramate Generic | 73 | 147 | 19 | $1,158 |
Brand drugs: 1,096 claims; generic drugs: 1,831 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alicia L Duyvejonck $21K ($21K in general payments such as food, travel and fees) from 10 companies. The largest payer was Lundbeck LLC with $18K.
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 68 | $18K |
| Abbvie Inc. ABBV | 18 | $2,959 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $137 |
| Eisai Inc. 4523.T | 1 | $116 |
| Axsome Therapeutics, Inc. AXSM | 2 | $78.6 |
| Pfizer Inc. PFE | 2 | $50.27 |
| TG Therapeutics, Inc. TGTX | 2 | $32.92 |
| Lilly USA, LLC LLY | 1 | $21.85 |
| UCB, Inc. UCB.BR | 1 | $17.36 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $15.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.